Autolus Therapeutics AUTL
NASDAQ AUTL
$2.24 -0.05 (-2.18%)
As of: Sep 4, 2026 · 3:59 PM EDT

Autolus Therapeutics (AUTL) EV to CFO (2018 - 2025)

Analysis

Autolus Therapeutics (AUTL) EV to CFO (2018 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Autolus Therapeutics 594.86 Mn 393.23 Mn 25.22 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -6.03
Sep 30, 2025 -3.11
Jun 30, 2025 -9.40
Mar 31, 2025 -0.45
Dec 31, 2024 -6.49
Sep 30, 2024 -8.21
Jun 30, 2024 -10.34
Mar 31, 2024 -37.13
Dec 31, 2023 -58.53
Sep 30, 2023 -8.85
Jun 30, 2023 -8.31
Mar 31, 2023 -3.27
Dec 31, 2022 -7.90
Sep 30, 2022 -6.96
Jun 30, 2022 -9.48
Mar 31, 2022 -13.73
Dec 31, 2021 -67.99
Sep 30, 2021 -21.64
Jun 30, 2021 -19.71
Mar 31, 2021 -15.26